David Chachkhiani

M.D. | Neurology


  1270 Attakapas Dr Ste 401, Opelousas
     Louisiana, 70570-6557
  337-678-4152    337-942-7122 Maps & Directions
David Chachkhiani is a Opelousas, Louisiana based neurologist who is specialized in Neurology. His current practice location is 1270 Attakapas Dr Ste 401, Opelousas. Patients can reach him at 337-678-4152 or can fax him at 337-942-7122. David Chachkhiani is M.D. in Neurology and his NPI number (Unique professional ID assigned by NPPES) is 1164953006.
David Chachkhiani specializes in the diagnosis and treatment of diseases or impaired function of the brain, spinal cord, peripheral nerves, muscles, autonomic nervous system, and blood vessels that relate to these structures.
Complete Profile:
David Chachkhiani speciality, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for appointment.
Name: David Chachkhiani
Specialization: Neurology
Gender:Male
Credentials: M.D.
Practice Address:1270 Attakapas Dr Ste 401, Opelousas,
Louisiana, 70570-6557
Phone:337-678-4152
Fax:337-942-7122
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS). NPI details are as mentioned below.
NPI Number: 1164953006
NPI Enumeration Date: 22 Mar, 2017
NPI Last Update On: 10 Oct, 2022

Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address: David Chachkhiani
1270 Attakapas Dr Ste 401,
Opelousas, Louisiana
Zip: 70570-6557
Phone Number: 337-678-4152
Fax Number: 337-942-7122
Patients can reach David Chachkhiani at 1270 Attakapas Dr Ste 401, Opelousas, Louisiana or can call to book an appointment on 337-678-4152.
Comments/ Reviews:

Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 March, 2024.